For the Inventor, By the Inventor

Enter assignee name

Fremont, CA, United States of America

Amgen Fremont Inc.

USPTO Granted Patents = 78

% Expired Patents = 53.8

CIPO Patents = 16

EPO Patents = 38

Forward Citations = 1,326

Loading Chart...

Loading Chart...

147 inventors (with patents filed for the assignee):

Larry L Green (34 out of 71 patents)

Jose Corvalan (26 out of 34 patents)

Xiao-Chi Jia (22 out of 57 patents)

4. Ian Nevin Foltz (20 out of 68 patents)

5. Jaspal Singh Kang (17 out of 41 patents)

6. Vahe Bedian (15 out of 29 patents)

7. Xiao Feng (15 out of 22 patents)

8. Orit Foord (14 out of 78 patents)

9. Scott L Klakamp (14 out of 16 patents)

10. Chadwick Terence King (13 out of 59 patents)

11. Bruce Alan Keyt (11 out of 43 patents)

12. Palaniswami Rathanaswami (11 out of 14 patents)

13. Qiaojuan Jane Su (11 out of 18 patents)

14. Mary Haak-Frendscho (11 out of 47 patents)

15. C Geoffrey Davis (11 out of 15 patents)

Core Competencies:

CTLA-4

Epidermal Growth Factor Receptor

Monoclonal Antibodies

Cancer Treatments

M-CSF

Antibody Engineering

Tumor Necrosis Factor

Insulin-Like Growth Factor

CD40

OPGL

TGF-Beta

Myostatin

78 patents: Sort by Forward Citations

1. 11492411 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2022-11-08),

2. 10508153 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2019-12-17),

3. 10280219 - Antibodies to M-CSF (2019-05-07),

4. 10259872 - Antibodies to MAdCAM (2019-04-16),

5. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2018-11-06),

6. 9963508 - Human monoclonal antibodies to CTLA-4 (2018-05-08),

7. 9718883 - Antibodies to M-CSF (2017-08-01),

8. 9580503 - Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof (2017-02-28),

9. 9328169 - Human antibodies that bind human MAdCAM (2016-05-03),

10. RE45847 - Antibodies to MAdCAM (2016-01-18),

11. 9238691 - Nucleic acids encoding antibodies to CCR2 (2016-01-19),

12. 9234041 - Antibodies to insulin-like growth factor I receptor (2016-01-12),

13. 9221915 - Human monoclonal antibodies to activin receptor-like kinase-1 (2015-12-29),

14. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2015-08-04),

15. 9085624 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2015-07-21),

Amgen Fremont Inc. is a leading biotechnology company headquartered in Fremont, California. Our mission is to serve patients by discovering, developing, and delivering innovative medicines and therapeutic solutions. As a subsidiary of Amgen Inc., we are committed to transforming the practice of medicine and improving lives worldwide. With state-of-the-art facilities and a dedicated team of scientists, researchers, and professionals, Amgen Fremont continues to drive advancements in biotechnology and contribute to the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

78 Patents

#35 in Fremont, CA

#1,095 in California

#4,728 in US

#9,647 in the World

Fremont, CA, United States of America

Amgen Fremont Inc.

Forward Citations = 1,326

147 inventors:

Larry L Green (34 out of 71 patents)

Jose Corvalan (26 out of 34 patents)

Xiao-Chi Jia (22 out of 57 patents)

4. Ian Nevin Foltz (20 out of 68 patents)

5. Jaspal Singh Kang (17 out of 41 patents)

Please report any incorrect information to [email protected]

Loading…